We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

0AB6 Hyloris Pharmaceuticals Sa

0.00 (0.00%)

Hyloris Pharmaceuticals Financial Summary

The current 0AB6 market cap is 0. The company's latest EPS is EUR -0.3846 and P/E is -32.11.

Year End 31 December 2022 20182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 91k91k175k3.1M2.95M
Operating Income -5.47M-5.27M-7.05M-10.54M-10.64M
Net Income -5.79M-5.37M-7.15M-11.58M-10.77M
Year End 31 December 2022 20182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 7.95M5.98M69.18M63.44M61.86M
Total Liabilities 12.41M16.17M10.12M15.39M6.82M
Total Equity -4.46M-10.19M59.06M48.06M55.05M

Cash Flow

Year End 31 December 2022 20182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Operating -5.37M-4.56M-4.57M-11.25M-13.15M
Investing 19k-1.23M-633k-3.08M-1.24M
Financing 7.77M3.31M69.4M-62k7.84M
Market Cap 0
Price to Earnings Ratio -32.11
Price to Sales Ratio 117.17
Price to Cash Ratio 7.96
Price to Book Ratio 6.28
Dividend Yield -

Share Statistics

Shares Outstanding 28M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0 (0%)

Company Info

Company Name Hyloris Pharmaceuticals Sa
Address boulevard patience et beaujonc
liege, liege 4000
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |